Copper homeostasis and cuproptosis in Alzheimer's disease (Review)
Authors:
Open Access
- 21 August 2025
- journal article
- review article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 56 (5) , 1-21
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by neuroinflammation, synaptic dysfunction and neuronal loss. Research has revealed a connection between copper metabolism and the pathophysiology of AD, particularly through a newly identified form of copper‑dependent cell death referred to as cuproptosis. Cuproptosis is driven by the aggregation of lipoylated proteins and proteotoxic stress caused by excessive copper accumulation, leading to cellular demise, which is a key event in AD. While studies on copper levels in the brain in AD remain inconclusive, there is mounting evidence suggesting that an imbalance in copper homeostasis, particularly elevated labile copper levels, contributes to oxidative damage and neurodegeneration in patients with AD. The present review examines the role of cuproptosis in AD and discusses how targeting this pathway may provide novel therapeutic opportunities. By investigating the underlying mechanisms and potential clinical implications, the present review highlights that regulation of cuproptosis provides a promising approach for modulating disease progression and developing personalized treatment strategies for AD.Keywords
This publication has 285 references indexed in Scilit:
- Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron effluxProceedings of the National Academy of Sciences, 1999
- Ceruloplasmin Ferroxidase Activity Stimulates Cellular Iron Uptake by a Trivalent Cation-specific Transport MechanismJournal of Biological Chemistry, 1999
- Decrease of cytochrome c oxidase protein in heart mitochondria of copper-deficient ratsBioMetals, 1998
- Copper absorption and bioavailabilityThe American Journal of Clinical Nutrition, 1998
- hCTR1: A human gene for copper uptake identified by complementation in yeastProceedings of the National Academy of Sciences, 1997
- The Yeast Fre1p/Fre2p Cupric Reductases Facilitate Copper Uptake and Are Regulated by the Copper-modulated Mac1p ActivatorJournal of Biological Chemistry, 1997
- Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stressJournal of the Neurological Sciences, 1996
- Copper biochemistry and molecular biologyThe American Journal of Clinical Nutrition, 1996
- Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentrationJournal of Neurology, 1993
- Dopamine beta-hydroxylase deficiency. A genetic disorder of cardiovascular regulation.Hypertension, 1991